These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6997226)

  • 1. Effect of bacterial metabolic state on vesical mucosal adherence.
    Shrom SH; Parsons CL; Fritz RW; Mulholland SG
    Invest Urol; 1980 Jul; 18(1):77-9. PubMed ID: 6997226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder defense mechanism.
    Mulholland SG; Parsons CL; Shrom SH; Murphy JJ
    Trans Am Assoc Genitourin Surg; 1976; 68():83-6. PubMed ID: 801214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesical defense: further evidence for a charge-related mucosal anti-adherence mechanism.
    Shrom SH; Parsons CL; Mulholland SG
    Surg Forum; 1978; 29():632-3. PubMed ID: 401419
    [No Abstract]   [Full Text] [Related]  

  • 4. Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect.
    Parsons CL; Shrom SH; Hanno PM; Mulholland SG
    Invest Urol; 1978 Nov; 16(3):196-200. PubMed ID: 30735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
    Lin LF; Zhu G; Yoo JJ; Soker S; Sukhatme VP; Atala A
    J Urol; 2002 Aug; 168(2):813-8. PubMed ID: 12131373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of soluble virulence factor by Escherichia coli.
    Mostafavi M; Stein PC; Parsons CL
    J Urol; 1995 May; 153(5):1441-3. PubMed ID: 7714961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesical defense: assessment of adsorption potential with live, dead, and metabolically inhibited Escherichia coli and 99mTC-labeled sulfur colloid particles.
    Shrom SH; Parsons CL; Alavi A; Mulholland SG
    Surg Forum; 1977; 28():565-7. PubMed ID: 364743
    [No Abstract]   [Full Text] [Related]  

  • 8. The primary antibacterial defense mechanism of the bladder.
    Parsons CL; Greenspan C; Mulholland SG
    Invest Urol; 1975 Jul; 13(1):72-8. PubMed ID: 1095522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bacterial attachment to acid treated bladder epithelium.
    Davis CP; Avots-Avotins AE
    Scan Electron Microsc; 1982; (Pt 2):825-30. PubMed ID: 6762651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of urothelial surface mucoprotein in intrinsic bladder defense.
    Shrom SH; Parsons CL; Mulholland SG
    Urology; 1977 May; 9(5):526-33. PubMed ID: 324090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rabbit vesical mucosa on bacterial growth.
    Mulholland SG; Foster EA; Paquin AJ; Gillenwater JY
    Invest Urol; 1969 May; 6(6):593-604. PubMed ID: 4890224
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ammonium on bacterial adherence to bladder transitional epithelium.
    Parsons CL; Stauffer C; Mulholland SG; Griffith DP
    J Urol; 1984 Aug; 132(2):365-6. PubMed ID: 6376829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sodium hyaluronate on epithelial healing of the vesical mucosa and vesical fibrosis in rabbits with acetic acid induced cystitis.
    Takahashi K; Takeuchi J; Takahashi T; Miyauchi S; Horie K; Uchiyama Y
    J Urol; 2001 Aug; 166(2):710-3. PubMed ID: 11458122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of surface mucin in primary antibacterial defense of bladder.
    Parsons CL; Greenspan C; Moore SW; Mulholland SG
    Urology; 1977 Jan; 9(1):48-52. PubMed ID: 831354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-adherence effect of heparin: a visual analysis.
    Chin JL; Sharpe JR
    Urol Res; 1983; 11(4):173-9. PubMed ID: 6359635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier.
    Nickel JC; Downey J; Morales A; Emerson L; Clark J
    J Urol; 1998 Aug; 160(2):612-4. PubMed ID: 9679938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate.
    Parsons CL
    J Urol; 1982 Jan; 127(1):167-9. PubMed ID: 6173492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin as antibacterial agent in rabbit bladder.
    Hanno PM; Fritz R; Wein AJ; Mulholland SG
    Urology; 1978 Oct; 12(4):411-5. PubMed ID: 362670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit urinary bladder blood flow changes during the initial stage of partial outlet obstruction.
    Lieb JI; Chichester P; Kogan B; Das AK; Leggett RE; Schröder A; Levin RM
    J Urol; 2000 Oct; 164(4):1390-7. PubMed ID: 10992421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice.
    Kerrn MB; Struve C; Blom J; Frimodt-Møller N; Krogfelt KA
    J Antimicrob Chemother; 2005 Mar; 55(3):383-6. PubMed ID: 15681580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.